ZNF423: A New Player in Estrogen Receptor-Positive Breast Cancer

Preventive therapy can target hormone-responsive breast cancer (BC) by treatment with selective estrogen receptor modulators (SERMs) and reduce the incidence of BC. Genome-wide association studies have identified single nucleotide polymorphisms (SNPs) with relevant predictive values, SNPs in the ZNF...

Full description

Saved in:
Bibliographic Details
Published in:Front Endocrinol (Lausanne)
Main Authors: Bond, Heather M., Scicchitano, Stefania, Chiarella, Emanuela, Amodio, Nicola, Lucchino, Valeria, Aloisio, Annamaria, Montalcini, Ylenia, Mesuraca, Maria, Morrone, Giovanni
Format: Artigo
Language:Inglês
Published: Frontiers Media S.A. 2018
Subjects:
Endocrinology
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5968090/
https://ncbi.nlm.nih.gov/pubmed/29867779
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fendo.2018.00255
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items